Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (Q4)Aug 31, 2025 | (Q3)May 31, 2025 | (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 22.18%258.38M | 10.45%62.55M | 18.05%49.4M | 23.51%66.96M | 35.19%79.47M | 11.34%211.48M | 9.94%56.63M | 1.45%41.85M | 26.16%54.22M | 11.23%58.78M |
| Cost of revenue | 23.04%235.6M | 14.52%55.87M | 17.92%44.2M | 22.85%60.81M | 34.08%74.72M | 5.88%191.49M | 11.20%48.78M | -5.64%37.48M | 16.26%49.5M | 3.59%55.73M |
| Gross profit | 13.93%22.78M | -14.88%6.69M | 19.14%5.2M | 30.43%6.15M | 55.52%4.75M | 120.15%19.99M | 2.71%7.85M | 186.41%4.36M | 1,090.66%4.72M | 420.48%3.05M |
| Operating expense | 6.28%14.06M | -9.67%3.13M | -5.28%3.34M | 24.41%4.13M | 9.11%3.23M | -10.58%13.23M | 11.24%3.46M | 18.48%3.53M | 23.03%3.32M | 14.01%2.96M |
| Selling and administrative expenses | 5.87%14.06M | -9.67%3.13M | -5.28%3.34M | 24.41%4.13M | 9.11%3.23M | 19.18%13.29M | 11.24%3.46M | 18.48%3.53M | 23.03%3.32M | 14.01%2.96M |
| -General and administrative expense | 5.87%14.06M | -9.67%3.13M | -5.28%3.34M | 24.41%4.13M | 9.11%3.23M | 19.18%13.29M | 11.24%3.46M | 18.48%3.53M | 23.03%3.32M | 14.01%2.96M |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | -99.54%17.09K | ---- | ---- | ---- | ---- |
| Total other operating income | --0 | ---- | ---- | ---- | ---- | -30.65%69.23K | ---- | ---- | ---- | ---- |
| Operating profit | 28.91%8.71M | -19.00%3.56M | 122.13%1.86M | 44.74%2.02M | 1,618.18%1.51M | 218.19%6.76M | -3.15%4.39M | 157.54%836K | 160.71%1.4M | 102.48%88K |
| Net non-operating interest income (expenses) | 12.66%-3.14M | 7.77%-819K | 20.23%-840K | 9.00%-859K | 3.13%-930K | 14.85%-3.59M | 19.93%-888K | 2.50%-1.05M | 19.18%-944K | 10.95%-960K |
| Non-operating interest income | 15.25%350.76K | ---- | ---- | ---- | ---- | 41.82%304.35K | ---- | ---- | ---- | ---- |
| Non-operating interest expense | -10.48%3.49M | -7.77%819K | -20.23%840K | -9.00%859K | -3.13%930K | -12.11%3.9M | -19.93%888K | -2.50%1.05M | -19.18%944K | -10.95%960K |
| Net investment income | -99.61%32 | -39.98%8.25K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Special income (charges) | -66.17%453.3K | 28.72%-1.56M | 0 | 0 | 0 | 216.72%1.34M | 10.90%-2.19M | 0 | 0 | 0 |
| Less:Other special charges | 42.22%-2.05M | ---- | ---- | ---- | ---- | ---3.55M | ---- | ---- | ---- | ---- |
| Less:Write off | -27.71%1.6M | -28.72%1.56M | --0 | --0 | --0 | 92.55%2.21M | -10.90%2.19M | --0 | --0 | --0 |
| Other non-operating income (expenses) | -33.98%280.27K | -22.51%475K | -88.36%112K | -60.18%133K | -21.11%1.9M | 26.52%424.5K | 100.33%613K | 751.33%962K | 183.05%334K | 1,791.34%2.4M |
| Income before tax | 27.74%6.31M | -14.23%1.65M | 51.54%1.13M | 64.68%1.3M | 61.90%2.48M | 145.47%4.94M | 53.51%1.93M | 130.79%745K | 118.84%787K | 133.98%1.53M |
| Income tax | -101.18%-7.48K | 250.00%203K | -7.11%183K | -25.74%176K | -1.38%143K | -59.70%632.41K | -93.56%58K | -55.23%197K | 30.22%237K | 18.85%145K |
| Net income | 46.68%6.31M | -22.44%1.45M | 72.63%946K | 103.64%1.12M | 68.52%2.33M | 134.64%4.31M | 428.90%1.87M | 119.16%548K | 112.62%550K | 129.95%1.39M |
| Net income continuous operations | 46.68%6.31M | -22.44%1.45M | 72.63%946K | 103.64%1.12M | 68.52%2.33M | 134.64%4.31M | 428.90%1.87M | 119.16%548K | 112.62%550K | 129.95%1.39M |
| Noncontrolling interests | 18.74%1.27M | 8.91%611K | 1,585.71%208K | -13.52%371K | 68.18%185K | -15.24%1.07M | 338.72%561K | -101.65%-14K | -43.77%429K | 146.61%110K |
| Net income attributable to the company | 55.89%5.05M | -35.91%837K | 31.32%738K | 519.01%749K | 68.55%2.15M | 123.65%3.24M | 122.11%1.31M | 115.16%562K | 102.36%121K | 129.06%1.28M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 55.89%5.05M | -35.91%837K | 31.32%738K | 519.01%749K | 68.55%2.15M | 123.65%3.24M | 122.11%1.31M | 115.16%562K | 102.36%121K | 129.06%1.28M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 48.98%0.0073 | -40.00%0.0012 | 27.91%0.0011 | 478.95%0.0011 | 60.00%0.0032 | 121.59%0.0049 | 115.05%0.002 | 113.65%0.0009 | 102.18%0.0002 | 127.03%0.002 |
| Diluted earnings per share | 73.81%0.0073 | -21.43%0.0011 | 32.20%0.0008 | 507.69%0.0008 | 76.92%0.0023 | 118.50%0.0042 | 122.22%0.0014 | 109.37%0.0006 | 101.49%0.0001 | 117.57%0.0013 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.